Aandeel CLS B CLINICAL LASERTHERMIA SYSTEMS AB
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Clinical Laserthermia Systems AB

Aandelen

CLS B

SE0022049920

Vertraagde tijd Nasdaq Stockholm
Andere beurzen
 16:55:14 28-06-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
5,869 SEK +0,55% Intraday-grafiek van Clinical Laserthermia Systems AB -2,13% -78,74%
25/06 Clinical Laserthermia Systems sluit Italiaanse distributieovereenkomst voor laserablatietherapie MT
25/06 Clinical Laserthermia Systems AB (publ) sluit een exclusieve distributieovereenkomst met Tecnogamma s.r.l. CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!
Gratis inschrijven
CLS announces outcome of rights issue
Communique from the Annual General Meeting on Friday June 28th in Clinical Laserthermia Systems AB
Clinical Laserthermia Systems Signs Italian Distribution Deal for Laser Ablation Therapy
CLS enters the Italian market for Focal Laser Ablation together with the Nationwide Italian Company Tecnogamma s.r.l.
Clinical Laserthermia Systems AB Enters into an Exclusive Distribution Agreement with Tecnogamma S.r.l
Recruitment of Glioblastoma Patients to the CLS-sponsored Clinical Study at Skåne University Hospital is now Completed
Clinical Laserthermia Systems AB Announces Completion of Clinical Study At Skane University Hospital
Clinical Laserthermia Systems publishes supplementary prospectus regarding ongoing rights issue
CLS receives additional order for ClearPoint Prism products corresponding to approximately SEK 7.5 million
Clinical Laserthermia Systems AB Receives Additional Order for Clearpoint Prism Products Associated to Approximately SEK 7.5 Million
CLS publishes prospectus in connection with forthcoming rights issue
Clinical Laserthermia Systems publishes annual report for 2023
BioStock: CLS' partner initiates full market release in the US
First Clinical Data from the Investigator-initiated study with CLS Focal Laser Ablation system at the University Hospital Magdeburg will be presented at the Nordkongress in Lübeck 13-15 June 2024
CLS presents its new strategic direction in a Business Update Event on June 12
CLS Commercial Partner is Initiating Full Market Release of ClearPoint Prism 3T Neuro Laser Therapy System in The U.S
Clinical Laserthermia Systems to Raise SEK59 Million via Rights Issue
CLS resolves on a partially guaranteed Rights Issue of approximately SEK 59m
CLS publishes interim report January - March 2024
Clinical Laserthermia Systems AB Reports Earnings Results for the First Quarter Ended March 31, 2024
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers CLS B
  4. Nieuws Clinical Laserthermia Systems AB
  5. Andere talen